A Study to Assess Mass Balance Recovery, Metabolite Profile and Identification of IV and Oral 14C-BC-3781
Clinical trial NCT03131141 · COMPLETED
Trial details
- NCT number
- NCT03131141
- Sponsor
- Nabriva Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-08
- Primary completion
- 2017-10-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.